Medtronic's profit dropped 69% on patent-litigation and acquisition-related charges as the medical-device maker saw sales of its implantable cartioverter defibrillators fall.
WSJ.com: US Business, Wall Street Journal: Business
Tue, 05/19/2009 - 4:52am
Medtronic's profit dropped 69% on patent-litigation and acquisition-related charges as the medical-device maker saw sales of its implantable cartioverter defibrillators fall.